Open Government Portal
Found 10 records similar to Appearance of the Hon. Steven Guilbeault Minister of Canadian Heritage Before the Standing Committee on Industry, Science and Technology (INDU) – Study of the Canadian response to the COVID-19 pandemic
Briefing binder used by the Privacy Commissioner of Canada, Daniel Therrien, as a witness before the Standing Committee on INDU on May 29, 2020 on the Canadian Response to the COVID-19 Pandemic.
The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care during recovery. However, post COVID-19 condition may also occur for people with mild or asymptomatic infection who were asked to isolate at home during the infectious phase.
People infected with COVID-19 can shed the virus through their stool, even if they don't have any symptoms. Testing a community's sewage (wastewater) can tell us if COVID-19 is increasing or decreasing in that community. Our scientists have developed a pan-Canadian wastewater network to monitor the spread of COVID-19 in Canada. This is in collaboration with provincial, territorial and municipal governments and academia across Canada.
During the COVID-19 pandemic, the CFIA is delivering critical services that protect food safety, animal health, plant health and market access. Appropriate oversight of domestic production and imported food products are essential to providing safe food for consumers while supporting trade and the supply chain. As the COVID-19 pandemic situation continues to evolve, the CFIA will seek to review and adjust its response efforts accordingly. The CFIA will continue to actively review its response to COVID-19 and adjust as appropriate.
The coronavirus disease (COVID-19) pandemic has had unprecedented consequences for Canada's aging population with the majority of COVID-19 deaths (approximately 80% during 2020) occurring among adults aged 65 years and older. Both advanced age and underlying chronic diseases and conditions contribute to these severe outcomes.
Excess mortality refers to additional mortality above the expected level (based on mortality in the same period in the preceding year or averaged over several preceding years in the same population). This measure allows for the measurement of death directly and indirectly related to COVID-19 and provides a summary measure of its whole system impact in addition to its impact on mortality.
COVID-19 is an illness caused by a coronavirus. Human coronaviruses are common and are typically associated with mild illnesses, similar to the common cold.
When people still show symptoms of COVID-19 for weeks or months after their initial recovery, it’s called post COVID-19 condition. It’s also known as long COVID. Post COVID-19 condition may occur in some people after infection.
Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.
Supportive online resources to help with pain management during COVID-19.